Metabolically engineered bacterial strains having...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/31 (2006.01) C07K 14/24 (2006.01) C12N 1/20 (2006.01) C12N 1/21 (2006.01) C12P 7/40 (2006.01) C12P 7/58 (2006.01)

Patent

CA 2526595

The present invention relates to engineering metabolic pathways in bacterial host cells which results in enhanced carbon flow for the production of ascorbic acid (ASA) intermediates. In particular, the invention relates to increasing the production of ASA intermediates in bacterial cells by enhancing the availability of gluconate resulting from the inactivation of endogenous gluconate transporter genes.

L'invention se rapporte à la manipulation de voies métaboliques dans des cellules hôtes bactériennes, de manière à obtenir une circulation améliorée du carbone servant à la production d'intermédiaires de l'acide ascorbique (ASA). L'invention porte en particulier sur l'accroissement de la production d'intermédiaires de l'ASA dans les cellules bactériennes, obtenu par augmentation la biodisponibilité du gluconate résultant de l'inactivation des gènes des transporteurs de gluconate endogènes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Metabolically engineered bacterial strains having... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Metabolically engineered bacterial strains having..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metabolically engineered bacterial strains having... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1355529

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.